The occurrence of alpha-heavy chain disease in an Italian adult, working in Libya, is reported, characterized by a spontaneous clinical and immunological recovery. It is suggested that the patient could have acquired the disease during his stay in an endemic area of alpha-heavy chain disease, and that the observed spontaneous remission could be related to the removal of environmental pathogenic factors, following his departure from Libya.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Urine analysis in monoclonal gammopathies at diagnosis: settling cut-off values.
Adv Lab Med
December 2024
Laboratory Department, Sant Joan Despí Moisès Broggi Hospital, CLILAB Diagnòstics, Barcelona, Spain.
Objectives: Laboratory testing has an extensive role in the diagnosis of monoclonal gammopathies. Since the last updates of the International Myeloma Working Group (IMWG) guidelines for the diagnosis of monoclonal gammopathies, debate has arisen as to whether urine analysis remains relevant for the diagnosis of these entities.
Methods: We carried out a retrospective study with data from 132 patients with a newly diagnosed serum M-protein.
Gastrointestinal Alpha Heavy Chain Disease With Persistent Colonization and Refractory Giardiasis.
ACG Case Rep J
August 2024
Department of Gastroenterology and Hepatobiliary Diseases, New York Medical College, Valhalla, NY.
Alpha heavy chain disease (αHCD) is a rare variant of the mucosa-associated lymphoid tissue lymphoma characterized by expression of a monotypic truncated immunoglobulin α heavy chain. αHCD frequently involves the gastrointestinal (GI) tract, and its pathogenesis has been linked to clonal B-cell expansion from chronic immune stimulation by infectious agents. We report a rare case of GI αHCD with 5 concomitant pathogens identified on a GI multiplex real-time polymerase chain reaction panel, featured by persistent colonization and refractory giardiasis.
View Article and Find Full Text PDFTreatment-Resistant Immunoproliferative Small Intestinal Disease (IPSID) Leading to Lymphoma.
Cureus
June 2024
Department of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, USA.
Article Synopsis
- Immunoproliferative small intestinal disease (IPSID) is a type of MALT lymphoma, mainly affecting the proximal small intestine and linked to chronic infection, causing symptoms like malabsorption and weight loss.
- A case study of a 50-year-old Nigerian woman highlights the diagnostic challenges of IPSID, as her symptoms were initially misattributed to other conditions despite multiple antibiotic treatments.
- The patient's condition progressed from initial symptom relief with antibiotics to requiring chemotherapy after developing lymphoma, illustrating the complexities of managing IPSID effectively.
The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
Curr Oncol
May 2022
Section of Hematology and Bone Marrow Transplant, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.
Immunoproliferative small intestinal disease (IPSID) is an uncommon disease with a higher prevalence in the developing world. IPSID diagnosis relies mainly on a tissue biopsy and a high index of suspicion. Treatment options are variable; however, they mainly include anthracycline-based chemotherapy with or without antibiotics in advanced stages.
View Article and Find Full Text PDFAims: Cerebral amyloidomas (CAs) are mass-producing congophilic lesions most commonly due to λ light chain deposits, contrasting them with light chain deposition disease (LCDD) which has non-polarizable, often κ light chain deposition.
Materials And Methods: Although usual histological features are well known, we detail 3 recent CAs with unusual morphological findings and review the literature specifically for these features.
Results: Two women, aged 56 and 58 years, had right cerebral white matter CAs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!